MétaCan
Menu
Back to cohort

Expanding Horizons for Psychedelic-Assisted Therapy & Management Scholarship: European Perspectives

2025· article· en· W4416005197 on OpenAlexaff
Adelaide Wilcox King, Bennet A. Zelner, Michael Lounsbury

Bibliographic record

VenueAcademy of Management Proceedings · 2025
Typearticle
Languageen
FieldPsychology
TopicPsychedelics and Drug Studies
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsGlobal mental healthMental healthScholarshipAnxietyProductivityDepression (economics)Global healthGreat Depression

Abstract

fetched live from OpenAlex

The global mental health crisis represents one of the grand challenges of our time. Rates of already-common conditions such as depression and anxiety rose by more than 25% in the first year of the COVID pandemic, adding to the nearly one billion people who were already living with a mental disorder. Depression is ranked by the World Health Organization (WHO) as the single largest contributor to global disability while anxiety ranks sixth. Lost productivity from depression and anxiety has been estimated to cost the global economy US $1 trillion per year and is forecast to reach $16 trillion by 2030. The global mental health crisis has engendered a mindful search for alternative treatments to the current pharmaceutical-centered approach, which has been unable to provide sustained relief for many who suffer despite the vast increase in the use of antidepressants and other psychiatric drugs in recent decades. Psychedelic-assisted therapy (PAT) has emerged as a leading option, and the psychedelic drug market is projected to generate $7.2 billion by 2029. For the past two years, we have run successful interdisciplinary symposia exploring the potential of PAT to refresh dominant organizational assumptions and foster new paradigms in the delivery of mental healthcare. Building on these efforts, we propose a new symposium for AoM 2025 to support the expansion of management scholarship on this critically important topic while leveraging AoM 2025’s European location. Europe offers a fertile landscape for organizational scholars to explore the complexities of PAT, informed by distinct regulatory, cultural, and socio-political contexts. Countries such as the UK, the Netherlands, and Germany have long played pivotal roles in advancing PAT through clinical trials, regulatory innovation, and public-private partnerships. The symposium will explore how European leaders in policy, advocacy, research, and media view the ecosystem of psychedelic-assisted therapy, and how these insights inform possibilities for organization scholars to engage generatively with this burgeoning field. The panelists – Henrik Jungaberle of the MIND Foundation (Germany), Tadeusz Hawrot of the Psychedelic Access and Research European Alliance, Josh Hardman of Psychedelic Alpha (UK), and Anne Philippi of the New Health Club (Germany) – will illuminate the interplay of scientific, organizational, and institutional influences in the emergence of an ethical and legal PAT industry from its underground roots.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.041
metaresearch head score (Gemma)0.021
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: Theoretical or conceptual
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.041
Threshold uncertainty score0.218

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0410.021
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0040.004
Science and technology studies0.0090.023
Scholarly communication0.0240.023
Open science0.0030.018
Research integrity0.0200.015
Insufficient payload (model declined to judge)0.0130.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.398
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designTheoretical or conceptual
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAcademy of Management ProceedingsSame topicPsychedelics and Drug StudiesFrench-language works237,207